Capacity

Comments from the Expert meeting

To be able to analyse if the capacity in Europe can meet the testing demands in the future, e.g. REACH, more background information is needed. For example which areas of toxicity testing will be of most importance for in vitro methods in the future? The demand depends primarily on regulation aspects. It is also important to define the steps of the development process before it is possible to identify if there is insufficient capacity at any particular step. However, reliability, continuity, GLP and knowledge in how to use the new methods are always aspects of significance when estimating capacity.

It is important to keep close contact with the different organisations representing the final users of toxicity tests, e.g. IVTIP (the In Vitro Testing Industrial Platform), EPAA (the European Partnership for Alternative Approaches to Animal Testing) and Europa-Bio (the European Association for Bioindustries).